Pro Medicus Limited ( (AU:PME) ) has issued an announcement.
Pro Medicus Limited announced the cessation of 1,220 ordinary fully paid securities due to an on-market buy-back, effective March 28, 2025. This move is part of the company’s capital management strategy, potentially impacting its financial structure and shareholder value by reducing the number of outstanding shares.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, providing advanced imaging software and services primarily for medical professionals and healthcare facilities. The company focuses on delivering innovative solutions that enhance diagnostic imaging capabilities and streamline healthcare workflows.
YTD Price Performance: -16.19%
Average Trading Volume: 504
Technical Sentiment Signal: Sell
Current Market Cap: $13.29B
Learn more about PME stock on TipRanks’ Stock Analysis page.